Vickie Reed
Director/Board Member bei EVOKE PHARMA, INC.
Vermögen: - $ am 31.03.2024
Profil
Gegenwärtig ist Vickie S. Reed die Position des Chief Financial & Accounting Officer bei Mirati Therapeutics, Inc. inne. Außerdem ist sie Mitglied des Vorstands von Evoke Pharma, Inc. Vickie S. Reed erwarb einen Bachelor-Abschluss an der University of Colorado.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EVOKE PHARMA, INC.
-.--% | 10.05.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Vickie Reed
| Unternehmen | Position | Beginn |
|---|---|---|
| EVOKE PHARMA, INC. | Director/Board Member | 13.05.2021 |
| DMK PHARMACEUTICALS CORPORATION | Director/Board Member | 24.05.2022 |
Ehemalige bekannte Positionen von Vickie Reed
| Unternehmen | Position | Ende |
|---|---|---|
| MIRATI THERAPEUTICS | Director of Finance/CFO | 16.05.2022 |
| ZOGENIX, INC. | Director of Finance/CFO | 01.01.2022 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Ausbildung von Vickie Reed
| The University of Colorado | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EVOKE PHARMA, INC. | Health Technology |
| DMK PHARMACEUTICALS CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
